/ CompletedNot ApplicableIIT Post-market, Randomized, Controlled, Prospective Study Evaluating Intrathecal Pain Medication (IT) Versus Conventional Medical Management (CMM) in the Non-cancer, Refractory, Chronic Pain Population (PROSPER)
This study is being conducted to compare intrathecal morphine using the commercially available intrathecal drug delivery systems (IDDS), and conventional medical management (CMM) in subjects with non-cancer, refractory chronic pain.
100 Clinical Results associated with Bond Pharmacy, Inc.
0 Patents (Medical) associated with Bond Pharmacy, Inc.
100 Deals associated with Bond Pharmacy, Inc.
100 Translational Medicine associated with Bond Pharmacy, Inc.